Moreover, the tumor persistence despite the intense T cell infiltration in HVEM deficient tumors may reflect the ability of BTLA still present on tumor cells to engage HVEM expression on stromal cells to condition the tumor microenvironment and therefore override the function of tumor infiltrating immune cells. This evidence concerns the gene BTLA and neoplasm.